Top Markets
Coin of the day
Ocean Biomedical, Inc. Ocean Biomedical, Inc.

Ocean Biomedical, Inc.

OCEAW
Hisse Senetlerindeki Sıralama #33294
Ocean Biomedical, Inc. is a biopharmaceutical enterprise primarily engaged in... Ocean Biomedical, Inc. is a biopharmaceutical enterprise primarily engaged in identifying and advancing novel therapeutic agents. Their research and development efforts span several key disease areas, including cancer, fibrotic conditions, infectious illnesses, and inflammatory disorders. The company's current development pipeline features both mono-specific and bi-specific humanized monoclonal antibodies (mAbs). These candidates are engineered to target Chi3l1 and are being investigated for treating non-small cell lung cancer and glioblastoma multiforme, a type of brain tumor. Furthermore, Ocean Biomedical is progressing a small molecule therapeutic designed to interact with Chit1, intended for individuals afflicted with Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. Their proprietary WPDS platform has generated three additional product candidates: a vaccine aimed at preventing malaria; a humanized monoclonal antibody treatment; and a small molecule treatment, with both malaria therapeutics specifically targeting the Plasmodium falciparum glutamic-acid-rich protein (PfGARP). The company is also developing a therapy for hospitalized patients suffering from COVID-19. Founded in 2019, Ocean Biomedical's operations are headquartered in Providence, Rhode Island.
Hisse Fiyatı
$0.0298
Son senkronizasyon: 2026-02-10
Piyasa Değeri
$7.94M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
664.10%
Ülke
US
Ticaret Ocean Biomedical, Inc. (OCEAW)

Kategori

Ocean Biomedical, Inc. (OCEAW) için temettü verimi geçmişi
Ocean Biomedical, Inc. (hisse sembolü: OCEAW) temettü verimi (TTM) 2026 itibariyle: 0
Son 5 yılın ortalama temettü verimi: 0.00%
Ocean Biomedical, Inc. (OCEAW) için 2026 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin temettü verimi (TTM)